​
​

Renovaro Biosciences (ENOB) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Renovaro Biosciences Revenue Highlights

00

Renovaro Biosciences Revenue by Period

Renovaro Biosciences Revenue by Year

DateRevenueChange
2024-06-30-100.00%
2023-06-30-100.00%
2022-06-30-100.00%
2021-06-30-100.00%
2020-06-30-100.00%
2019-06-30-100.00%
2018-06-30-100.00%
2017-06-30--100.00%
2016-06-30$42.77K100.00%
2014-12-31--100.00%
2013-03-31$-37.09K100.00%
2012-03-31-100.00%
2011-12-31--

Renovaro Biosciences generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Renovaro Biosciences Revenue by Quarter

DateRevenueChange
2024-09-30--100.00%
2024-06-30$181.45K100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30--100.00%
2016-06-30$244.00100.00%
2016-03-31--100.00%
2015-12-31$42.52K100.00%
2015-09-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30--

Renovaro Biosciences generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Renovaro Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ADAGAdagene$18.11M$833.34K
MOLNMolecular Partners$7.04M$2.74M
MNOVMediciNova$1.00M-
ANEBAnebulo Pharmaceuticals--
RZLTRezolute--
ANTXAN2 Therapeutics--
PHVSPharvaris--
AVTEAerovate Therapeutics--
CYTCyteir Therapeutics--
ELYMEliem Therapeutics--
ACRVAcrivon Therapeutics--
PMVPPMV Pharmaceuticals--
MLYSMineralys Therapeutics--
ENOBRenovaro Biosciences--
PEPGPepGen--
CSBRChampions Oncology--

ENOB Revenue FAQ

What is Renovaro Biosciences’s yearly revenue?

Renovaro Biosciences's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ENOB's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Renovaro Biosciences’s quarterly revenue?

Renovaro Biosciences's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $181.45K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). ENOB's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

What is Renovaro Biosciences’s revenue growth rate?

Renovaro Biosciences's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.